cytarabine and 2,3-dihydro-1h-imidazo(1,2-b)pyrazole

cytarabine has been researched along with 2,3-dihydro-1h-imidazo(1,2-b)pyrazole in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carter, GL; Cory, JG	1
Bhalla, K; Cadman, E; Grant, S; Rauscher, F	1

Other Studies

2 other study(ies) available for cytarabine and 2,3-dihydro-1h-imidazo(1,2-b)pyrazole

Article	Year
Factors affecting the mRNA levels for the non-heme iron and effector-binding subunits of ribonucleotide reductase. Advances in enzyme regulation, 1992, Volume: 32 Topics: Animals; Calcium; Cycloheximide; Cytarabine; Dactinomycin; Deoxyadenosines; Gene Expression Regulation, Neoplastic; Hydroxyurea; Leukemia L1210; Metalloproteins; Nonheme Iron Proteins; Protein Biosynthesis; Pyrazoles; Ribonucleotide Reductases; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured	1992
Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60. Cancer research, 1983, Volume: 43, Issue:11 Topics: Antineoplastic Agents; Biological Transport; Cell Division; Cell Line; Cell Survival; Clone Cells; Cytarabine; Deoxyribonucleosides; DNA Replication; Drug Synergism; Humans; Leukemia, Myeloid, Acute; Pyrazoles	1983

Article

Year

Factors affecting the mRNA levels for the non-heme iron and effector-binding subunits of ribonucleotide reductase.

Advances in enzyme regulation, 1992, Volume: 32

Topics: Animals; Calcium; Cycloheximide; Cytarabine; Dactinomycin; Deoxyadenosines; Gene Expression Regulation, Neoplastic; Hydroxyurea; Leukemia L1210; Metalloproteins; Nonheme Iron Proteins; Protein Biosynthesis; Pyrazoles; Ribonucleotide Reductases; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured

1992

Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.

Cancer research, 1983, Volume: 43, Issue:11

Topics: Antineoplastic Agents; Biological Transport; Cell Division; Cell Line; Cell Survival; Clone Cells; Cytarabine; Deoxyribonucleosides; DNA Replication; Drug Synergism; Humans; Leukemia, Myeloid, Acute; Pyrazoles

1983